Neurolytic Block Techniques In Abdominal Visceral Cancer Pain
NCT06978673
Abdominal Cancer, Abdominal Pain
São Paulo, Brazil
View Trial DetailsNCT Number: NCT07357350
The goal of this prospective observational study is to observe the effectiveness of pain management interventions in patients with abdominal and pelvic cancer pain.
The main question[s] it aims to answer are:
* The effectiveness of pain management interventions. * The frequency of pain intervention procedures and side effects and complications of pain management interventions
Trial opening soon.
Get Notified18 year–65 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: First visit and then at 3 months
Numeric Rating Score from 0 (no pain)- 10 (severe pain)
Time frame: From 2 weeks to 3 months.
Number of patients on whom the intervention is performed.
Contact information is provided by the study sponsor or research team.
Aga Khan University
Other
Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer in a Tertiary Care Hospital: A Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06978673
Abdominal Cancer, Abdominal Pain
São Paulo, Brazil
View Trial DetailsNCT00493688
Abdominal Cancer, Neoplasms
Houston, Texas, United States
View Trial DetailsNCT05751837
Abdominal Cancer, Malignancy
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07594691
Abdominal Cancer
Toronto, Ontario, Canada
View Trial Details